Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

May 08 • 04:00PM ET

75.04

+1.94 2.66 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: LKFT ROIV APLS VERA KYMR

| Held by: IWM VTI XBI VXF IBB IWO SCHA VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	13.28%	Shs Outstand	78.84M	Perf Week	8.10%
Market Cap	6.52B	Forward P/E	-	EPS next Y	-3.10	Insider Trans	-2.36%	Shs Float	75.33M	Perf Month	44.96%
Enterprise Value	5.93B	PEG	-	EPS next Q	-0.72	Inst Own	85.69%	Short Float	15.50%	Perf Quarter	113.68%
Income	-168.74M	P/S	-	EPS this Y	-44.98%	Inst Trans	23.44%	Short Ratio	10.99	Perf Half Y	228.42%
Sales	0.00M	P/B	11.49	EPS next Y	-7.91%	ROA	-25.30%	Short Interest	11.67M	Perf YTD	129.08%
Book/sh	6.53	P/C	8.79	EPS next 5Y	-21.18%	ROE	-29.26%	52W High	76.00 -1.26%	Perf Year	483.55%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	12.28 510.87%	Perf 3Y	1799.87%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.08% 7.14%	Perf 5Y	-58.54%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.26	Perf 10Y	-65.54%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	67.64	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	6.21%	Beta	3.12	Target Price	94.13
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	36.32%	Rel Volume	0.79	Prev Close	73.10
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	130.10%	Avg Volume	1.06M	Price	75.04
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	840,626	Change	2.66%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)